RecruitingPhase 2NCT07089043

A Study in Subjects With Neurogenic Orthostatic Hypotension

Studying Rare autonomic nervous system disorder

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CuraSen Therapeutics, Inc.
Principal Investigator
Chief Medical Officer
CuraSen Therapeutics, Inc.
Intervention
CST-3056(drug)
Enrollment
12 target
Eligibility
18-85 years · All sexes
Timeline
2025 – 2026

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07089043 on ClinicalTrials.gov

Other trials for Rare autonomic nervous system disorder

Additional recruiting or active studies for the same condition.

See all trials for Rare autonomic nervous system disorder →

← Back to all trials